Tissuemed raises $9.75 million for product launch:
This article was originally published in Clinica
UK company Tissuemed has raised £6.5 million ($9.75 million), which it will use towards the European launch of its surgical adhesive product, tissuebond, later this year. The Leeds-based company, which plans to float within the next 18 months, has also received a further £2 million from 3i. Tissuemed believes its product will overcome the drawbacks of surgical sealants and that sales of the product will be significant. The product has been CE-marked as a haemostat, sealant and aid to anastomosis.